Form4insider filings, from the source

SEC Form 4 · accession 0001140361-18-024520

Cimarex Resolute LLC · REN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Monarch GP LLC
Director · Other
MDRA GP LP
Director · Other
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 9:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469510

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001 per shareF1,F2,F3,F4May 15, 2018A2,770$0.00A2,770ISee footnotes
Common StockF3,F5holding———70,868ISee footnotes
Common StockF3,F6holding———543,931ISee footnotes
Common StockF3,F7holding———452,297ISee footnotes
Common StockF3,F8holding———862,721ISee footnotes
Common StockF3,F9holding———338,254ISee footnotes
Common StockF3,F10holding———329ISee footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Joseph Citarrella, a Managing Principal of Monarch Alternative Capital LP, serves on the board of directors of the Issuer as a representative of Monarch Alternative Capital LP. As a result, each of Monarch Alternative Capital LP, and by virtue of their control of Monarch Alternative Capital LP, MDRA GP LP and Monarch GP LLC is a "director-by-deputization" solely for purposes of Section 16 of the Exchange Act. Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filers' Information and Signatures